tradingkey.logo
tradingkey.logo

Surgery Partners Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 5, 2025 1:32 PM
  • Surgery Partners Inc SGRY.OQ reported quarterly adjusted earnings of 17 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 21 cents. The mean expectation of twelve analysts for the quarter was for earnings of 13 cents per share. Wall Street expected results to range from 1 cents to 24 cents per share.

  • Revenue rose 8.4% to $826.20 million from a year ago; analysts expected $816.97 million.

  • Surgery Partners Inc's reported EPS for the quarter was a loss of 2 cents​.

  • The company reported a quarterly loss of $2.5 million.

  • Surgery Partners Inc shares had fallen by 0.1% this quarter and gained 4.9% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 28.9% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

  • Wall Street's median 12-month price target for Surgery Partners Inc is $33.00, about 32.7% above its last closing price of $22.22

This summary was machine generated from LSEG data August 5 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

0.13

0.17

Beat

Mar. 31 2025

0.05

0.04

Missed

Dec. 31 2024

0.38

0.44

Beat

Sep. 30 2024

0.25

0.19

Missed

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI